Literature DB >> 10579905

The IGF-I receptor in cancer research.

R Baserga1.   

Abstract

The type 1 insulin-like growth factor receptor (IGF-IR) plays an important role in both normal and abnormal growth. It is particularly important in anchorage-independent growth. Impairment of its function causes apoptosis of tumor cells and inhibition of tumor growth in experimental animals. However, the IGF-IR can also induce differentiation, and eventually cell death, of certain types of cells. Its major substrates, IRS-1 and Shc, determine whether the IGF-IR will transform cells or will cause their differentiation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579905     DOI: 10.1006/excr.1999.4667

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  72 in total

1.  Insulin-like growth factor in muscle growth and its potential abuse by athletes.

Authors:  G R Adams
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

2.  Transmission of cutaneous infections in athletes.

Authors:  B B Adams
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

Review 3.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

4.  The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Authors:  Matthew J Martin; Nataliya Melnyk; Michelle Pollard; Mary Bowden; Hon Leong; Thomas J Podor; Martin Gleave; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 5.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.

Authors:  Lauren M Rota; Lidia Albanito; Marcus E Shin; Corey L Goyeneche; Sain Shushanov; Emily J Gallagher; Derek LeRoith; Deborah A Lazzarino; Teresa L Wood
Journal:  Cancer Res       Date:  2014-08-04       Impact factor: 12.701

7.  Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.

Authors:  Young Wha Koh; Dok Hyun Yoon; Cheolwon Suh; Hee Jeong Cha; Jooryung Huh
Journal:  Int J Exp Pathol       Date:  2015-04-27       Impact factor: 1.925

8.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

9.  IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report.

Authors:  Adam Kuklinski; Zbigniew Kamocki; Mariusz Koda; Zdzislaw Piotrowski; Stanislaw Sulkowski; Ryszard Lesniewicz; Krystyna Pawlak; Piotr Mysliwiec; Boguslaw Kedra
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

10.  Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation.

Authors:  R Novosyadlyy; A Vijayakumar; D Lann; Y Fierz; N Kurshan; D LeRoith
Journal:  Oncogene       Date:  2009-07-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.